{"guideline_source":"NCCN Guidelines Version 1.2025","recommendation_summary":"For patients with Stage III melanoma with clinically positive nodes (cN+), the recommended primary treatment is wide local excision (WLE) and complete lymph node dissection (CLND). Adjuvant systemic therapy options include nivolumab or pembrolizumab, both of which are category 1 recommendations. Observation is also an option.","reference_section":"ME-5"}
